Pfizer Limited v. Ratiopharm Inc., 2010 FCA 204
Justice Nadon; Justice Sharlow; Justice Layden-Stevenson - 2010-07-29
Read full decision. Automatically generated summary:
The respondent (Ratiopharm), pursuant to the provisions of the Patent Act, R.S.C. 1985, c. P.4 (the Act), commenced an action in the Federal Court with respect to the appellants (Pfizer) Canadian Letters Patent No. 1,321,393 (the '393 Patent). Ratiopharm requested, among other things, a declaration that the '393 Patent is invalid. A Federal Court judge (the trial judge) granted Ratiopharms request.
Decision relates to: